Clinical Trial Update: Long-Acting Growth Hormone in Children Compared to Daily rhGH [Phase 3]

View source ↗

Summary

Phase 3 trial comparing long-acting growth hormone to daily rhGH in children with growth disorders has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Growth Disorders

Drugs mentioned

• Long-acting growth hormone (long-acting growth hormone)
• rhGH (growth hormone)

Snippet

Sponsor: Versartis Inc. | Conditions: Growth Disorders | Phase 3 | Status: COMPLETED | Results posted: 2022-12-30